Advanced search
Publication Cover
Immunological Investigations
A Journal of Molecular and Cellular Immunology
Volume 46, 2017 - Issue 4
Submit an article Journal homepage
221
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression

Ya CaoJiangsu Key Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China;Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
,
Haitao HuangDepartment of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, China;Department of Thoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
,
Zhenxin WangJiangsu Key Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China;Department of Medical Oncology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaView further author information
&
Guangbo ZhangJiangsu Key Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, ChinaCorrespondence[email protected]
View further author information
Pages 361-374 | Published online: 04 Apr 2017

Citations (26)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Zulei Zhang, Yuting Chen, Yaofei Jiang, Yan Luo, Hao Zhang & Yakun Zhan. (2019) Prognostic and clinicopathological significance of CXCL1 in cancers: a systematic review and meta-analysis. Cancer Biology & Therapy 20:11, pages 1380-1388.
Read now
Kate Rittenhouse-Olson. (2019) Thematic 2019 Letter from the Editor. Immunological Investigations 48:7, pages 673-679.
Read now
Himadri Patel, Pritish Nilendu, Devashree Jahagirdar, Jayanta K. Pal & Nilesh Kumar Sharma. (2018) Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics. Cancer Biology & Therapy 19:1, pages 3-12.
Read now

Articles from other publishers (23)

Steven M. Albelda. (2023) CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn. Nature Reviews Clinical Oncology.
Crossref
Jingjing Guo, Baijie Tang, Jing Fu, Xuan Zhu, Wenlong Xie, Nan Wang, Zhiyong Ding, Zhentao Song, Yue Yang, Gang Xu & Xue Xiao. (2023) High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer. Cellular Oncology.
Crossref
Minjie Pan, Xiaoshan Wei, Xuan Xiang, Yanhong Liu, Qiong Zhou & Weibing Yang. (2023) Targeting CXCL9/10/11–CXCR3 axis: an important component of tumor-promoting and antitumor immunity. Clinical and Translational Oncology 25:8, pages 2306-2320.
Crossref
Tiantian Wu, Wannian Yang, Aiqin Sun, Zhixiao Wei & Qiong Lin. (2022) The Role of CXC Chemokines in Cancer Progression. Cancers 15:1, pages 167.
Crossref
Li Xia, Enming Tian, Mingcheng Yu, Chenglong Liu, Lian Shen, Yafei Huang, Zhongen Wu, Jinlong Tian, Ker Yu, Yonghui Wang, Qiong Xie & Di Zhu. (2022) RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Yifan Hu, Mintao Xiao, Duoli Zhang, Jing Shen, Yueshui Zhao, Mingxing Li, Xu Wu, Yu Chen, Zhigui Wu, Hongli Luo, Zhangang Xiao & Fukuan Du. (2022) Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma. Heliyon 8:11, pages e11399.
Crossref
Yonggui Tian, Chunli Wen, Zhen Zhang, Yanfen Liu, Feng Li, Qitai Zhao, Chang Yao, Kaiyuan Ni, Shengli Yang & Yi Zhang. (2022) CXCL9-modified CAR T cells improve immune cell infiltration and antitumor efficacy. Cancer Immunology, Immunotherapy 71:11, pages 2663-2675.
Crossref
Ioana Ghita, Evangelia Piperi, Sergei P. Atamas, Soren M. Bentzen, Robert A. Ord, Donita Dyalram, Joshua E. Lubek & Rania H. Younis. (2022) Cytokine profiling in plasma distinguishes the histological inflammatory subtype of head and neck squamous cell carcinoma and a novel regulatory role of osteopontin. Frontiers in Oral Health 3.
Crossref
Ellen J. Spartz, Matthew Wheelwright, Tetyana Mettler, Khalid Amin, Nabeel Azeem, Mohamed Hassan, Jacob Ankeny & James V. Harmon. (2022) Evaluation of abnormal gallbladder imaging findings: Surgical management and pathologic correlations in early‐stage gallbladder cancer. Clinical Case Reports 10:7.
Crossref
Jan Korbecki, Katarzyna Barczak, Izabela Gutowska, Dariusz Chlubek & Irena Baranowska-Bosiacka. (2022) CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space. International Journal of Molecular Sciences 23:2, pages 792.
Crossref
Kazuhiko Matsuo, Osamu Yoshie & Takashi Nakayama. (2021) Multifaceted Roles of Chemokines and Chemokine Receptors in Tumor Immunity. Cancers 13:23, pages 6132.
Crossref
Veethika Pandey, Alicia Fleming-Martinez, Ligia Bastea, Heike R Doeppler, Jillian Eisenhauer, Tam Le, Brandy Edenfield & Peter Storz. (2021) CXCL10/CXCR3 signaling contributes to an inflammatory microenvironment and its blockade enhances progression of murine pancreatic precancerous lesions.. eLife 10.
Crossref
Ronald Anderson, Ada Gabriela Blidner & Bernardo Leon Rapoport. (2021) Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Frontiers in Pharmacology 12.
Crossref
Yanan Wang, Jing Wang, Xinyi Yang, Jinlong Yang, Panpan Lu, Lin Zhao, Bokang Li, Hanyu Pan, Zhengtao Jiang, Xiaoting Shen, Zhiming Liang, Yue Liang & Huanzhang Zhu. (2021) Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model. Frontiers in Immunology 12.
Crossref
Ragaa Abdelkader Ramadan, Wafaa Ragab, Ramy Samir Assaad, Ahmed Elsayed Shaaban & Amira Ibrahim Fayad. (2020) Identification of serum biomarker panel to differentiate malignant from benign thyroid nodules using multiplex bead assay. Journal of the Egyptian National Cancer Institute 32:1.
Crossref
Charlotte Dahlem, Wei Xiong Siow, Maria Lopatniuk, William K. F. Tse, Sonja M. Kessler, Susanne H. Kirsch, Jessica Hoppstädter, Angelika M. Vollmar, Rolf Müller, Andriy Luzhetskyy, Karin Bartel & Alexandra K. Kiemer. (2020) Thioholgamide A, a New Anti-Proliferative Anti-Tumor Agent, Modulates Macrophage Polarization and Metabolism. Cancers 12:5, pages 1288.
Crossref
Elizabeth C. Eckert, Rebecca A. Nace, Jason M. Tonne, Laura Evgin, Richard G. Vile & Stephen J. Russell. (2020) Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9. Molecular Therapy - Oncolytics 16, pages 63-74.
Crossref
Shi Yong Neo & Andreas Lundqvist. 2020. Tumor Microenvironment. Tumor Microenvironment 45 51 .
Holger Bronger, Viktor Magdolen, Peter Goettig & Tobias Dreyer. (2019) Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors. Cancer and Metastasis Reviews 38:3, pages 417-430.
Crossref
Reynders, Abboud, Baragli, Noman, Rogister, Niclou, Heveker, Janji, Hanson, Szpakowska & Chevigné. (2019) The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment. Cells 8:6, pages 613.
Crossref
Katharina Helene Susek, Maria Karvouni, Evren Alici & Andreas Lundqvist. (2018) The Role of CXC Chemokine Receptors 1–4 on Immune Cells in the Tumor Microenvironment. Frontiers in Immunology 9.
Crossref
Lei Li, Yong-Dong Liu, Yu-Ting Zhan, Ying-Hui Zhu, Yan Li, Dan Xie & Xin-Yuan Guan. (2018) High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. Thoracic Cancer 9:7, pages 775-784.
Crossref
Chu Huyen, Bui Luyen, Ghulam Khan, Ha Oanh, Ta Hung, Hui-Jun Li & Ping Li. (2018) Chemical Constituents from Cimicifuga dahurica and Their Anti-Proliferative Effects on MCF-7 Breast Cancer Cells. Molecules 23:5, pages 1083.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.